Advances in Cannabinoid Pharmacology

Delves into the pharmacodynamics and pharmacokinetics of cannabinoids, examining their molecular targets and mechanisms of action. Key discussions focus on therapeutic applications in pain, neurodegenerative diseases, and metabolic disorders. The interplay of major and minor cannabinoids, as well as terpenes, is analyzed. Recent clinical and preclinical studies are showcased. Insights into dose optimization and drug interactions are provided. Challenges in translating laboratory findings into standardized therapies are addressed.

    Related Conference of Advances in Cannabinoid Pharmacology

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Advances in Cannabinoid Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in